Treatment of advanced non-small cell lung cancer

31Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the last decade the treatment of advanced-metastatic non-small cell lung cancer has substantially improved. If in the early 90s there was still concern about the real efficacy of chemotherapy over best suppotive care alone in the advanced setting, constant developments in clinical research have demonstrated the survival advantage of active anti-cancer drugs not only in the first-line setting, but, lately, even in patients with recurrent disease after failure of two previous chemotherapy lines. With the premises of high throughput technologies, translational research is aiming to characterize patients and tumors on a molecular basis. With pharmacogenomics it would then be possible to accurately predict patient outcome and tailor the treatment strategy according to the geno-phenotype of single patients. © 2006 Oxford University Press.

Cite

CITATION STYLE

APA

De Petris, L., Crinò, L., Scagliotti, G. V., Gridelli, C., Galetta, D., Metro, G., … de Marinis, F. (2006). Treatment of advanced non-small cell lung cancer. Annals of Oncology, 17(SUPPL. 2). https://doi.org/10.1093/annonc/mdj919

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free